McCann Corey
- SEC CIK
- 0001881049
No open-market purchases or sales filed in the past year.
Current role at each company
- PEAR Pear Therapeutics, Inc.President and CEOas of Feb 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McCann Corey as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | McCann CoreyPresident and CEO | SSaleClass A Common Stock | −34.7K | $1.13 | −$39.2K | −0.4%8.21M after |